InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Vistagen Therapeutics, Inc.

VTGN Clue Score33
United States Fiscal year ends March CIK 0001411685
$0.24 -4.10% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $0.24 −90.44% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Revenue1.3Operating income−10.2Net income−10.3Fiscal year 2018Revenue0.0 −100.0%Operating income−14.2Net income−14.3Fiscal year 2019Operating income−24.6Net income−24.6Fiscal year 2020Revenue0.0Operating income−20.8Net income−20.8Fiscal year 2021Revenue1.1Operating income−17.9Net income−17.9Fiscal year 2022Revenue1.1 +1.8%Operating income−47.8Net income−47.8Fiscal year 2023Revenue−0.2 −120.5%Operating income−59.3Net income−59.2EPS, diluted−8.51Fiscal year 2024Revenue1.1Operating income−33.0Net income−29.4EPS, diluted−1.52Fiscal year 2025Revenue0.5 −54.3%Operating income−56.0Net income−51.4EPS, diluted−1.67Fiscal year 2026Revenue1.3 +161.1%Operating income−72.1Net income−69.7EPS, diluted−1.83
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue 1.3 0.0 n/a 0.0 1.1 1.1 −0.2 1.1 0.5 1.3
Growth −100.0% +1.8% −120.5% −54.3% +161.1%
Operating income −10.2 −14.2 −24.6 −20.8 −17.9 −47.8 −59.3 −33.0 −56.0 −72.1
Net income −10.3 −14.3 −24.6 −20.8 −17.9 −47.8 −59.2 −29.4 −51.4 −69.7
Growth
EPS, diluted n/a n/a n/a n/a n/a n/a −8.51 −1.52 −1.67 −1.83

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2017Operating margin−819.9%Net margin−820.4%Free cash flow margin−600.1%Fiscal year 2018Fiscal year 2019Fiscal year 2020Fiscal year 2021Operating margin−1,646.1%Net margin−1,646.1%Free cash flow margin−1,133.4%Fiscal year 2022Operating margin−4,308.3%Net margin−4,306.8%Free cash flow margin−4,098.9%Fiscal year 2023Operating margin26,109.3%Net margin26,100.4%Free cash flow margin22,133.9%Fiscal year 2024Operating margin−3,103.5%Net margin−2,759.6%Free cash flow margin−2,426.0%Fiscal year 2025Operating margin−11,517.1%Net margin−10,579.8%Fiscal year 2026Operating margin−5,683.7%Net margin−5,491.3%
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Operating margin −819.9% n/a n/a n/a −1,646.1% −4,308.3% 26,109.3% −3,103.5% −11,517.1% −5,683.7%
Net margin −820.4% n/a n/a n/a −1,646.1% −4,306.8% 26,100.4% −2,759.6% −10,579.8% −5,491.3%
Free cash flow margin −600.1% n/a n/a n/a −1,133.4% −4,098.9% 22,133.9% −2,426.0% n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow−7.3Capital expenditure−0.2Free cash flow−7.5Fiscal year 2018Operating cash flow−9.1Capital expenditure−0.0Free cash flow−9.1Fiscal year 2019Operating cash flow−14.5Capital expenditure−0.2Free cash flow−14.7Fiscal year 2020Operating cash flow−15.8Capital expenditure0.0Free cash flow−15.8Fiscal year 2021Operating cash flow−12.1Capital expenditure−0.3Free cash flow−12.3Fiscal year 2022Operating cash flow−45.3Capital expenditure−0.2Free cash flow−45.5Fiscal year 2023Operating cash flow−49.7Capital expenditure−0.5Free cash flow−50.2Fiscal year 2024Operating cash flow−25.8Capital expenditure0.0Free cash flow−25.8Fiscal year 2025Operating cash flow−42.1Fiscal year 2026Operating cash flow−66.4
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Operating cash flow −7.3 −9.1 −14.5 −15.8 −12.1 −45.3 −49.7 −25.8 −42.1 −66.4
Capital expenditure −0.2 −0.0 −0.2 0.0 −0.3 −0.2 −0.5 0.0 n/a n/a
Free cash flow −7.5 −9.1 −14.7 −15.8 −12.3 −45.5 −50.2 −25.8 n/a n/a
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2017Cash2.9Shareholders’ equity0.6Fiscal year 2018Cash10.4Shareholders’ equity6.9Fiscal year 2019Cash13.1Shareholders’ equity7.1Fiscal year 2020Cash1.4Shareholders’ equity−5.7Fiscal year 2021Cash103.1Shareholders’ equity92.0Fiscal year 2022Cash68.1Shareholders’ equity64.7Fiscal year 2023Cash16.6Shareholders’ equity12.1Fiscal year 2024Cash119.2Shareholders’ equity114.3Fiscal year 2025Cash67.1Shareholders’ equity70.4Fiscal year 2026Cash30.8Shareholders’ equity35.5
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash 2.9 10.4 13.1 1.4 103.1 68.1 16.6 119.2 67.1 30.8
Shareholders’ equity 0.6 6.9 7.1 −5.7 92.0 64.7 12.1 114.3 70.4 35.5

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2026 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending March, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 31 Mar 2017 FY2018 31 Mar 2018 FY2019 31 Mar 2019 FY2020 31 Mar 2020 FY2021 31 Mar 2021 FY2022 31 Mar 2022 FY2023 31 Mar 2023 FY2024 31 Mar 2024 FY2025 31 Mar 2025 FY2026 31 Mar 2026
Margins
−819.9% n/a n/a n/a −1,646.1% −4,308.3% 26,109.3% −3,103.5% −11,517.1% −5,683.7%
−820.2% n/a n/a n/a −1,645.9% −4,306.5% 26,097.8% −2,759.2% −10,578.4% −5,490.8%
−820.4% n/a n/a n/a −1,646.1% −4,306.8% 26,100.4% −2,759.6% −10,579.8% −5,491.3%
−600.1% n/a n/a n/a −1,133.4% −4,098.9% 22,133.9% −2,426.0% n/a n/a
Spending
416.3% n/a n/a n/a 1,094.6% 3,192.8% −19,549.3% 1,881.8% 8,101.9% 4,332.1%
503.6% n/a n/a n/a 651.5% 1,215.5% −6,459.9% 1,321.7% 3,515.2% 1,451.6%
19.1% n/a n/a n/a 25.3% 18.1% −232.6% 0.0% n/a n/a
Returns
−1,665.4% −207.4% −347.5% n/a −19.5% −73.8% −490.5% −25.7% −73.0% −196.2%
−276.3% −127.2% −175.5% −359.9% −16.6% −64.0% −280.9% −23.7% −61.0% −143.5%
Balance and payout
83.4% 38.7% 49.5% 199.3% 15.1% 13.3% 42.7% 7.6% 16.5% 26.9%